Brief: Pharma Equity Subsidiary Gets Patent For Drug Compositions

Pharma Equity A/S

05/03/2024 11:42

March 5 (Reuters) - Pharma Equity Group A/S  PEGRP.CO :
    * REPONEX PHARMACEUTICALS RECEIVED NOTIFICATION FROM EPO ON
DECISION TO GRANT PATENT FOR DRUG COMPOSITIONS
    * PATENT IS VALID UNTIL 2035
    * WITH ATTAINMENT OF FULL SUPPLEMENTARY PROTECTION
CERTIFICATE
(SPC) EXTENSION, VALIDITY WILL EXTEND UNTIL 2040

Source text for Eikon:  ID:nGNE6tb5GK 
Further company coverage:  PEGRP.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))